Senior / Executive Medical Director, Clinical Development (Oncology)
Iambic Therapeutics
| Company | Iambic Therapeutics |
| Category | Healthcare |
| Location | San Diego |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | USD 270k–367k |
| Posted | 7 Aug 2026 |
| Last verified | 8 Aug 2026 |
| Source | Employer ATS (ashby) |
Description
JOB SUMMARY
We are seeking a Senior or Executive Medical Director to provide medical and clinical development leadership for our early-stage oncology portfolio. This individual will own the clinical strategy and execution for one or more assets from IND-enabling activities through first-in-human and early efficacy studies. You will serve as the clinical and scientific lead on cross-functional program teams, working closely with our discovery, translational, regulatory, and clinical operations groups — and directly alongside our AI/ML platform teams — to translate novel candidates into well-designed clinical programs.
This position will be based in our San Diego Headquarters.
Title and scope will be calibrated to the successful candidate's experience.
KEY RESPONSIBILITIES
- Serve as the clinical/medical lead for early-stage oncology programs, owning the clinical development strategy from IND through Phase 1 and early proof-of-concept.
- Author and drive the clinical components of IND submissions, including protocols, investigator's brochures, and clinical sections of regulatory documents; support and participate in health authority interactions (e.g., pre-IND, EOP1).
- Design first-in-human and early-phase oncology trials, including dose-escalation and dose-optimization strategies, biomarker and translational plans, and eligibility criteria.
- Provide ongoing medical monitoring and safety oversight for active trials, including review of emerging safety data, dose decisions, and management of study conduct in partnership with Clinical Operations and Pharmacovigilance.
- Partner with translational science and the AI/ML platform teams to define patient selection strategies, pharmacodynamic endpoints, and data-driven development hypotheses.
- Engage key opinion leaders, investigators, and study sites; represent programs to internal governance, partners, and, as appropriate, external stakeholders.
- Collaborate cross-functionally with Regulatory Affairs, CMC, Clinical Operations, Biostatistics, and Program Management to keep programs on strategy and on timeline.
- Contribute to portfolio-level decisions, candidate selection input, and business development / due diligence as needed.
QUALIFICATIONS
- M.D. or D.O. (or international equivalent); board eligibility/certification in hematology/oncology or medical oncology strongly preferred; exceptional candidates with PharmD and relevant oncology and clinical experience will be considered
- Meaningful drug-development experience in biotech or pharma. We anticipate roughly 5+ years for a Senior Medical Director and 8–10+ years for an Executive Medical Director; strong candidates across this range are encouraged to apply.
- Direct, hands-on experience authoring and executing IND submissions.
- Direct experience designing and running Phase 1 / early-phase oncology clinical trials.
- Demonstrated experience with oncology assets and a strong understanding of the oncology therapeutic and drug-development landscape.
- Working knowledge of GCP, ICH guidelines, and the global regulatory environment for oncology development.
PREFERRED QUALIFICATIONS
- Experience with small-molecule oncology programs and targeted therapies.
- Experience taking a program from candidate nomination or IND through clinical proof-of-concept.
- Comfort working in a fast-paced, data-rich, technology-forward environment and collaborating with computational and platform teams.
- Prior experience presenting to health authorities and/or supporting BD due diligence
ABOUT IAMBIC THERAPEUTICS
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical tr